Ziprasidone (marketed as Geodon, Zeldox by Pfizer and Zipwell by Actavis) was the fifth atypical antipsychotic to gain approval in the United States. It is approved by the U.S. (FDA) for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. Ziprasidone is also used off-label for depression, bipolar maintenance, and PTSD.
- ProName: Ziprasidone
- CasNo:146939-27-7
- Appearance: White to off-white powder
- Application: API
- PackAge: 25kg/drum;200kg/drum
- Purity: 0.99
- Storage: Keep away of light，cool place
- Transportation: Sea/air/courier
No comments:
Post a Comment